KNTE Stock Forecast & Price Target
KNTE Stock
Price Forecast
The average stock forecast for
Kinnate Biopharma Inc (KNTE) in the next 12 months is 2.41 USD. This price target corresponds to an upside
of
-9.04%. The range of stock forecasts for KNTE is 2.02 - 2.72 USD.
Based on the ratings of 10 analysts, the consensus recommendation for KNTE is
HOLD.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
2.02 |
2.41 |
2.55 |
2.72 |
| Upside |
-23.77% |
-9.04% |
-3.77% |
2.62% |
Recommendation Trends
The latest consensus rating for KNTE is "HOLD". This is the average
recommendation of 10 analysts: 0 strong sell,
0 sell, 4 hold, 3 buy, 3 strong buy. In the previous period, 12 analysts also majorly recommmended
"HOLD" for KNTE.
KNTE Financial Stock
Forecast
Revenue This Year
from -M
Revenue Next Year
from -M